Amphastar Accounts Payable from 2010 to 2024

AMPH Stock  USD 43.57  0.07  0.16%   
Amphastar's Accounts Payable is increasing with slightly volatile movements from year to year. Accounts Payable is estimated to finish at about 32.3 M this year. Accounts Payable is the amount Amphastar P owes to suppliers or vendors for products or services received but not yet paid for. It represents Amphastar's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2012-12-31
Previous Quarter
31.8 M
Current Value
34.1 M
Quarterly Volatility
48.4 M
 
Yuan Drop
 
Covid
Check Amphastar financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amphastar's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.9 M, Interest Expense of 28.5 M or Selling General Administrative of 46.2 M, as well as many indicators such as Price To Sales Ratio of 4.86, Dividend Yield of 0.0 or PTB Ratio of 4.9. Amphastar financial statements analysis is a perfect complement when working with Amphastar Valuation or Volatility modules.
  
Check out the analysis of Amphastar Correlation against competitors.

Latest Amphastar's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Amphastar P over the last few years. An accounting item on the balance sheet that represents Amphastar obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Amphastar P are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Amphastar's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amphastar's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Amphastar Accounts Payable Regression Statistics

Arithmetic Mean27,964,111
Geometric Mean22,969,386
Coefficient Of Variation81.26
Mean Deviation15,044,311
Median20,380,000
Standard Deviation22,723,852
Sample Variance516.4T
Range77.3M
R-Value0.29
Mean Square Error509.8T
R-Squared0.08
Significance0.30
Slope1,466,045
Total Sum of Squares7229.2T

Amphastar Accounts Payable History

202432.3 M
202325.4 M
202220.5 M
202122.2 M
202024.4 M
201977.1 M
201887.4 M

About Amphastar Financial Statements

Investors use fundamental indicators, such as Amphastar's Accounts Payable, to determine how well the company is positioned to perform in the future. Although Amphastar's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Accounts Payable25.4 M32.3 M

Currently Active Assets on Macroaxis

When determining whether Amphastar P offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amphastar's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amphastar P Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amphastar P Stock:
Check out the analysis of Amphastar Correlation against competitors.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.14)
Earnings Share
3.01
Revenue Per Share
14.942
Quarterly Revenue Growth
0.059
Return On Assets
0.0867
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.